5-hydroxymethylcytosine sequencing in plasma cell-free DNA identifies unique epigenomic features in prostate cancer patients resistant to androgen deprivation therapy
Qianxia Li, Chiang‐Ching Huang, Shane Huang, Yijun Tian, Jinyong Huang, Amirreza Bitaraf, Xiaowei Dong, Marja T. Nevalanen, Manishkumar Patel, Jodie Wong, Jingsong Zhang, Brandon J. Manley, Jong Y. Park, Manish Kohli, Elizabeth Gore, , Liang Wang
This study identifies 5hmC-based gene set activity scores in cfDNA as biomarkers for early detection of ADT resistance in prostate cancer.
medRxiv · Oct 13, 2023 · PreprintGenetic & Genomic Medicine